Filing Details
- Accession Number:
- 0000950170-24-068937
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-04 18:05:03
- Reporting Period:
- 2024-06-03
- Accepted Time:
- 2024-06-04 18:05:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1653087 | Alector Inc. | ALEC | Biological Products, (No Disgnostic Substances) (2836) | 822933343 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1748894 | Marc Grasso | C/O Alector, Inc. 131 Oyster Point Blvd., Suite 600 South San Francisco CA 94080 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-03 | 6,920 | $4.80 | 138,037 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
- The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.7986 to $4.7988. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.